Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F O Kelsey

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Teratology|September 1, 1988
Thalidomide update: regulatory aspectsF O Kelsey
Acta Morphologica Academiae Scientiarum Hungaricae|January 1, 1980
The importance of epidemiology in identifying drugs which may cause malformations--with particular reference to drugs containing sex hormonesF O Kelsey
Journal of the Parenteral Drug Association|March 1, 1980
FDA's biomedical research programF O Kelsey
Teratology|April 1, 1982
Regulatory aspects of teratology: role of the Food and Drug AdministrationF O Kelsey
Journal of Clinical Pharmacology|January 1, 1978
Biomedical monitoringF O Kelsey
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1973
Drugs in pregnancy and their effects on pre- and postnatal developmentF O Kelsey
Progress in Clinical and Biological Research|January 1, 1985
Drug labeling for teratogenicity: requirements of the U.S. Food and Drug AdministrationF O Kelsey
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1982
FDA's Bioresearch Monitoring ProgramF O Kelsey
Lancet (London, England)|June 24, 1989
Good clinical practice in clinical researchS L Nightingale, F O Kelsey
Teratology|June 1, 1986
Teratogen update: vitamin A congenersF W Rosa, A L Wilk, F O Kelsey
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Teratology|September 1, 1988
Thalidomide update: regulatory aspectsF O Kelsey
Acta Morphologica Academiae Scientiarum Hungaricae|January 1, 1980
The importance of epidemiology in identifying drugs which may cause malformations--with particular reference to drugs containing sex hormonesF O Kelsey
Journal of the Parenteral Drug Association|March 1, 1980
FDA's biomedical research programF O Kelsey
Teratology|April 1, 1982
Regulatory aspects of teratology: role of the Food and Drug AdministrationF O Kelsey
Journal of Clinical Pharmacology|January 1, 1978
Biomedical monitoringF O Kelsey
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1973
Drugs in pregnancy and their effects on pre- and postnatal developmentF O Kelsey
Progress in Clinical and Biological Research|January 1, 1985
Drug labeling for teratogenicity: requirements of the U.S. Food and Drug AdministrationF O Kelsey
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1982
FDA's Bioresearch Monitoring ProgramF O Kelsey
Lancet (London, England)|June 24, 1989
Good clinical practice in clinical researchS L Nightingale, F O Kelsey
Teratology|June 1, 1986
Teratogen update: vitamin A congenersF W Rosa, A L Wilk, F O Kelsey
Pageof 1